MBD4 and colorectal carcinoma: This well-powered study provides strong evidence that monoallelic pathogenic variant carriers in MUTYH, regardless of family history of CRC, as well as other recessive-acting genes, such as NTHL1, MSH3, and MBD4 do not have an increased CRC risk.